Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings.

D'Oria F, Piscazzi F, Facheris P, Foggi G, Ardigò M, Costanzo A, Valenti M

Open source

DOI
10.1007/s13555-026-01742-w
Published
2026 Jun
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01742-w,
  title = {Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings.},
  author = {D'Oria F and Piscazzi F and Facheris P and Foggi G and Ardigò M and Costanzo A and Valenti M},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01742-w},
  url = {https://doi.org/10.1007/s13555-026-01742-w}
}

RIS

TY  - JOUR
TI  - Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings.
AU  - D'Oria F
AU  - Piscazzi F
AU  - Facheris P
AU  - Foggi G
AU  - Ardigò M
AU  - Costanzo A
AU  - Valenti M
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01742-w
UR  - https://doi.org/10.1007/s13555-026-01742-w
ER  - 

APA

F, D., F, P., P, F., G, F., M, A., A, C., & M, V. (2026). Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01742-w

Source records